Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 17, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
Tuesday, September 16, 2014
Study demonstrate a dependency on gut bacteria for strong immune responses to the seasonal flu and inactivated polio vaccines.

DNASTAR Awarded Antibody Engineering Software SBIR Grant
Tuesday, September 16, 2014
Company receives Phase II SBIR grant award from the National Institutes of Health.

MabVax Enters Agreements with MSKCC and Juno
Friday, September 12, 2014
Agreement for the development of novel therapeutic products using antibody targeting sequences.

Blocking One Receptor on Cells Could Halt Rheumatoid Arthritis
Friday, September 12, 2014
Researchers uncovered multiple pathological processes driven by the activation of the receptor.

New Defence Mechanism Against Viruses Discovered
Friday, September 12, 2014
Mechanism may represent one of the oldest defence mechanisms against viruses in evolutionary history.

Seattle Genetics and Genmab Collaborate
Friday, September 12, 2014
Collaboration combines Genmab’s proprietary antibodies and Seattle Genetics’ ADC technology. The new ADC program will target AXL expressed on multiple tumor types.

Center for Advanced Cellular Therapeutics to Rise on Penn Medicine Campus
Friday, September 12, 2014
New facility poised to accelerate the research and development of personalized cellular cancer therapies.

Seattle Genetics and Genmab Enter into New ADC Collaboration
Thursday, September 11, 2014
New ADC program will target AXL expressed on multiple tumor types.

Allergopharma and S-TARget Conclude Licensing Agreement
Wednesday, September 10, 2014
Objective is new generation of therapeutics for allergy treatment.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1173
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv